Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

154
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
154
Neural Regulation01:37

Neural Regulation

39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical constituents of Bauhinia brachycarpa and their inhibitory activities against α-glucosidase and pancreatic lipase.

Fitoterapia·2026
Same author

Enhanced Hydrogen Evolution over Single-Atom Catalysts via Electrostatic Polarization in Contact-electro-catalysis.

Journal of the American Chemical Society·2026
Same author

Lecanemab Reduces Neuropsychiatric Symptoms and Related Regional Brain Amyloid Load in Early Alzheimer's Disease: A Preliminary Prospective Study.

CNS neuroscience & therapeutics·2026
Same author

Pharmacokinetics and Dosimetry of <sup>177</sup>Lu-DOTATATE in Patients with Advanced Well-Differentiated, Gastroenteropancreatic Neuroendocrine Tumors: Results from a Substudy of the Phase 3 XT-XTR008-3-01 Trial.

Molecular pharmaceutics·2026
Same author

Comparative performance of semi-quantitative methods for amyloid deposition in preclinical autosomal dominant Alzheimer's disease.

Alzheimer's research & therapy·2026
Same author

MSDDG: Multi-scale dual-discriminator GAN for point cloud completion of plant.

Plant phenomics (Washington, D.C.)·2026

Related Experiment Video

Updated: May 13, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

910

Deep learning for Parkinson's disease classification using multimodal and multi-sequences PET/MR images.

Yan Chang1,2, Jiajin Liu3, Shuwei Sun3

  • 1Medical School of Chinese PLA, Beijing, China.

EJNMMI Research
|May 9, 2025
PubMed
Summary

Deep learning accurately differentiates Parkinson's disease (PD) from multiple system atrophy (MSA) using multi-modal imaging. The combined 11C-CFT and ADC model achieved high accuracy, aiding in diagnosing these similar neurological conditions.

Keywords:
ClassificationDeep learningMulti-modalMulti-sequencePET/MRParkinson’s disease

More Related Videos

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

4.5K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Related Experiment Videos

Last Updated: May 13, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

910
Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology
09:44

Author Spotlight: Advancing Large-Scale Neural Dynamics Through HD-MEA Technology

Published on: March 8, 2024

4.5K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.6K

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Parkinson's disease (PD) and multiple system atrophy (MSA) exhibit overlapping clinical symptoms, complicating differential diagnosis.
  • Deep learning (DL) offers a promising approach for distinguishing between PD and MSA.

Purpose of the Study:

  • To develop and evaluate a DL model for accurate classification of PD, MSA, and normal controls (NC).
  • To assess the performance of multi-modal imaging in differentiating PD from MSA.

Main Methods:

  • Retrospective analysis of 206 patients (PD/MSA) and 38 NC using PET/MR imaging.
  • Training a modified 18-layer Residual Block Network (ResNet18) on 2D multi-modal image slices.
  • Utilizing a four-fold cross-validation and evaluating performance with accuracy, precision, recall, F1 score, ROC, and AUC.

Main Results:

  • Multi-modal models, particularly those combining PET and MRI data, outperformed single-modal approaches.
  • The 11C-CFT and Apparent Diffusion Coefficient (ADC) multi-modal model demonstrated superior classification performance.
  • The best-performing model achieved 0.97 accuracy, 0.93 precision, 0.95 recall, 0.92 F1, and 0.96 AUC in the training set.

Conclusions:

  • The developed DL method shows significant potential as an assistive tool for accurate PD and MSA diagnosis.
  • Multi-modal and multi-sequence DL models can enhance the classification accuracy for PD and related disorders.